Drug Shortage Report for CHOLESTYRAMINE-ODAN

Last updated on 2021-04-28 History
Report ID 135762
Drug Identification Number 02455609
Brand name CHOLESTYRAMINE-ODAN
Common or Proper name Cholestyramine for Oral Suspension, USP
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CHOLESTYRAMINE RESIN
Strength(s) 4G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 30 x 4g
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-03-17
Actual start date 2021-03-17
Estimated end date 2021-05-03
Actual end date 2021-04-27
Shortage status Resolved
Updated date 2021-04-28
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-28 English Compare
v5 2021-04-27 French Compare
v4 2021-04-27 English Compare
v3 2021-03-18 English Compare
v2 2021-03-16 French Compare
v1 2021-03-16 English Compare

Showing 1 to 6 of 6